One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: results of the French FHU INOVPAIN registry study

por Lanteri-Minet, M., Fabre, R., Martin, C., Pradat, K., Alchaar, A., Bozzolo, E., Duchene, M. L., Van Obberghen, E. K., Donnet, A., Fontaine, D.
Publicado 2023